Important note: Information in this article was accurate in November 2003. The state of the art may have changed since the publication date.
 |
HIV Treatment Bulletin - November 2003
Polly Clayden, HIV i-Base
A research letter published in the 26 September issue of AIDS describes fast turnaround of point of care testing in labour and delivery using the OraQuick Rapid HIV-1 antibody test recently approved by the FDA.
Four Chicago hospitals, participating in the Mother Infant Rapid Intervention at Delivery (MIRIAD) Study, evaluated the difference in turnaround times between three hospitals where staff performed rapid tests on whole blood samples at point of care and a fourth where tests were performed in the hospital laboratory.
A total of 225 women were tested at the three hospitals offering point of care testing and 155 at the hospital using the laboratory. Standard enzyme immunoassay/western blot was used to confirm 100% of the test results.
A total of 225 women were tested at the three hospitals offering point of care testing and 155 at the hospital using the laboratory. Standard enzyme immunoassay/western blot was used to confirm 100% of the test results.
The investigators concluded: “We found that point of care HIV testing was feasible, accurate and timely. It permitted previously undiagnosed HIV-infected pregnant women to learn their HIV status quickly allowing for the opportunity to administer intrapartum and neonatal antiretroviral therapy, a measure proven to reduce mother to child transmission.”
Ref: Cohen MH, Olszewski Y, Branson B et al. Using point of care testing to make rapid HIV-1 tests in labour really rapid AIDS. 2003 Sep 26;17(14):2121-4.
031110
IB30409-24
©2003. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
